Search & Analyze
Popular Searches
Gland Pharma Ltd.
Healthcare₹2,387.100.06%
24 Jul, 4:01 PM
CMP₹2,387.10
Mkt Cap₹39.22K Cr
P/E38.18
P/B3.79
ROE7.82%
52W High₹2,574.00
52W Low₹1,575.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
38.18
P/B Ratio
3.79
EV/EBITDA
18.55
Price/Sales
6.10
Dividend Yield (%)
0.84
EPS (TTM ₹)
62.28
Book Value (₹)
627.91
ROE (%)
7.82
ROCE (%)
11.97
ROA (%)
6.41
EBITDA Margin (%)
22.59
Net Profit Margin (%)
12.44
Debt/Equity
0.03
Current Ratio
4.33
Interest Coverage
26.30
Asset Turnover
0.52
Working Capital/Sales
1.08
Core EBITDA Growth (%)
-1.38
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 34628.76 | 44007.08 | 36246.01 | 56647.22 | 56165.04 |
| Net Sales | 34628.76 | 44007.08 | 36246.01 | 56647.22 | 56165.04 |
| Total Income | 35976.52 | 46246.46 | 38650.64 | 58349.57 | 58301.12 |
| Total Expenditure | 21606.51 | 28905.56 | 25998.38 | 43316.49 | 43475.8 |
| Operating Profit | 14370.01 | 17340.9 | 12652.26 | 15033.08 | 14825.32 |
| Depreciation | 987.8 | 1102.96 | 1467.36 | 3445.66 | 3778.74 |
| Exceptional Items | — | — | -564.61 | — | — |
| Profit Before Tax | 13348.1 | 16185.52 | 10545.82 | 11325.42 | 10626.58 |
| Tax | 3378.47 | 4068.88 | 2735.39 | 3600.82 | 3641.32 |
| Profit After Tax (PAT) | 9969.63 | 12116.64 | 7810.43 | 7724.6 | 6985.26 |
| EPS (₹) | 63.07 | 73.81 | 47.44 | 46.9 | 42.4 |
| Dividend Payout % | — | — | — | 2000 | 1800 |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 163.59 | 164.3 | 164.7 | 164.71 | 164.76 |
| Reserves | 58614.62 | 71279.51 | 79405.87 | 87059.88 | 91342.13 |
| Shareholders Funds | 59032.42 | 71576.21 | 79587.22 | 87238.43 | 91507.41 |
| Total Debt | 40.69 | 39.33 | 38.21 | 3197.82 | 2692.14 |
| Total Liabilities | 64960.82 | 78336.21 | 87775.35 | 106108.09 | 111728.52 |
| Total Assets | 64960.82 | 78336.21 | 87775.35 | 106108.09 | 111728.52 |
| Book Value / Share | 359.302 | 434.8376 | 483.1243 | 529.5646 | 555.3951 |
| Assets | 64960.82 | 78336.21 | 87775.35 | 106108.09 | 111728.52 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 6049.29 | 7907.69 | 3639.68 | 9967.97 | 9147.3 |
| Investing Activities | -15240 | -10026.21 | 12081.88 | -17569.11 | 17047.36 |
| Financing Activities | 12384.6 | 348.98 | 149.19 | -7994.16 | -4334.76 |
| Net Cash Flow | 3193.89 | -1769.54 | 15870.75 | -15595.3 | 21859.9 |
GLAND
₹2,387.10
+0.06%